Volume Alert - PBCT 14.79 People's United Financial $PBCT

New Post Public Reply Private Reply Replies (0) Message Board

Nov 17, 2014 at 2:46 PM

Volume Alert - PBCT 14.79 People's United Financial $PBCT Hit a high today of 14.85 Closing the day 10:30 at 14.79 +0.01 +0.07% With a day low of 14.72 and a total volume of 832,152.

PBCT Recent Posts: http://investorshangout.com/Peoples-United-Fi...BCT-55052/

PBCT People's United Financial Recent Headline News

Buy-Rated Dividend Stocks In The Top 3: PBCT, SO, GEL
at The Street - Mon Nov 17, 9:30AM CST
These 3 dividend stocks are rated a Buy by TheStreet
PBCT: 14.84 (+0.06), GEL: 48.43 (+0.47), SO: 47.12 (+0.48)

Cost Control Drives People's United; Should We Hold? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 3:10PM CST
On Nov 10, 2014, we issued an updated research report on People's United Financial Inc. (PBCT).
PBCT: 14.84 (+0.06), PROV: 14.92 (+0.07), HFBC: 11.67 (unch), GSBC: 39.25 (-0.41)

Trade-Ideas: People's United Financial (PBCT) Is Today's "Barbarian At The Gate" Stock
at The Street - Thu Nov 13, 10:10AM CST
Trade-Ideas LLC identified People's United Financial (PBCT) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
PBCT: 14.84 (+0.06)

Post-Earnings Insight - People's United Financial
PR Newswire - Fri Oct 31, 8:15AM CDT
Investor-Edge.com has issued free post-earnings review on People's United Financial Inc. (NASDAQ: PBCT). On October 16, 2014, the company reported its financial results for Q3 FY14 (period ended September 30, 2014). Click on www.investor-edge.com/FreeReports to read our free earnings review on People's United Financial Inc. During Q3 FY14, the company's net income increased $3.1 million on a Y-o-Y basis, and its diluted EPS increased $0.02 from the preceding year quarter. Our free coverage report can be accessed at:
PBCT: 14.84 (+0.06)

Hudson City Q3 Earnings Beat on Lower Expenses, Down Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 22, 11:00AM CDT
Hudson City Bancorp, Inc. (HCBK) reported the fourth consecutive quarter of positive earnings surprise with the third-quarter 2014 earnings of 7 cents per share outpacing the Zacks Consensus Estimate by a penny.
PBCT: 14.84 (+0.06), NWBI: 12.98 (-0.07), MTB: 124.73 (-0.21), HCBK: 9.75 (-0.07)

7 Higher-Yielding Stocks With A Low Price To Book
Dividends4Life - Seeking Alpha - Wed Oct 22, 7:27AM CDT
When looking for value-priced stocks , the Price-To-Book (P/ ratio is one that I like to consider. P/B is calculated as share price divided by book value per share. Book value is most often calculated as Assets less Liabilities. Some people...
PBCT: 14.84 (+0.06), CINF: 50.97 (-0.07), ED: 62.58 (+0.55), MCY: 54.07 (+0.02), CVX: 115.89 (-0.43), ORI: 15.05 (-0.07), LG: 50.39 (+0.27)

Downgrade Alert for People's United Financial (PBCT)
Comtex SmarTrend(R) - Mon Oct 20, 7:06AM CDT
People's United Financial (NASDAQ

BCT) was downgraded from Outperform to Market Perform at Raymond James today. The stock closed yesterday at $13.82 on volume of 8.9 million shares, above average daily volume of 3.5 million. In the past 52 weeks, People's United Financial share prices have been bracketed by a low of $13.71 and a high of $15.70 and closed yesterday at $13.82, 1% above that low price. In the last five trading sessions, the 50-day moving average (MA) has fallen 0.2% while the 200-day MA has remained constant.
PBCT: 14.84 (+0.06)

Short Sellers Catch Recent Downturn
Markit - at Seeking Alpha - Mon Oct 20, 5:36AM CDT
The recent market downturn has seen shorts add to their already elevated positions in the wake of the S&P's 7% decline in the last month, which saw the most shorted companies fall by over twice the index average. In contrast to the events of...
PBCT: 14.84 (+0.06), VRSN: 60.54 (-0.13), KSS: 57.32 (+0.20), DO: 36.42 (+0.61), BTU: 11.64 (+0.25), WU: 18.14 (+0.03), GME: 44.23 (-0.17), CLF: 10.70 (+0.01), X: 36.34 (+0.10), ADT: 35.30 (-0.68)

People's United Reports In-Line Q3 Earnings, Revenues Down - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 17, 11:00AM CDT
People's United's (PBCT) third-quarter 2014 operating earnings of 21 cents per share came in line with the Zacks Consensus Estimate.
PBCT: 14.84 (+0.06), LPSB: 11.73 (unch), NFBK: 14.17 (-0.12), EBSB: 11.23 (-0.11)

Andrew Hersom Joins People's United Bank As Senior Vice President, Investor Relations
PR Newswire - Fri Oct 17, 7:03AM CDT
People's United Bank announced today its appointment of Andrew Hersom as Senior Vice President, Investor Relations, responsible for the organization's investor relations. Peter Goulding, who previously led both investor relations and corporate development, will now focus on the latter as Senior Vice President, Corporate Development and Strategic Planning at People's United.
PBCT: 14.84 (+0.06)

People's United Financial's (PBCT) CEO John Barnes on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 16, 8:46PM CDT

PBCT: 14.84 (+0.06)

People's United Finl (PBCT) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Thu Oct 16, 8:32PM CDT
The following People's United Finl (PBCT) conference call took place on October 16, 2014, 05:00 PM ET. This is a transcript of that earnings call:
PBCT: 14.84 (+0.06)

People's United Financial (PBCT) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 16, 3:55PM CDT

PBCT: 14.84 (+0.06)

More on People's United Q3 results
Seeking Alpha - at Seeking Alpha - Thu Oct 16, 3:31PM CDT

PBCT: 14.84 (+0.06)

People's United Financial EPS and revenue in-line
Seeking Alpha - at Seeking Alpha - Thu Oct 16, 3:12PM CDT

PBCT: 14.84 (+0.06)

People's United Financial Reports Third Quarter Net Income And Operating Earnings Of $0.21 Per Share
PR Newswire - Thu Oct 16, 3:05PM CDT
People's United Financial, Inc. (NASDAQ: PBCT) today reported net income of $61.6 million, or $0.21 per share, for the third quarter of 2014, compared to $58.5 million, or $0.19 per share, for the third quarter of 2013, and $72.3 million, or $0.24 per share, for the second quarter of 2014. Included in the second quarter's results is a net after-tax gain of $13.4 million ($0.04 per share) resulting from the formation of a merchant services joint venture. Operating earnings were $63.0 million, or $0.21 per share, for the third quarter of 2014, compared to $60.8 million, or $0.20 per share, for the third quarter of 2013, and $59.9 million, or $0.20 per share, for the second quarter of 2014.
PBCT: 14.84 (+0.06)

3 Buy-Rated Dividend Stocks: FCX, EPD, PBCT
at The Street - Thu Oct 16, 10:30AM CDT
These 3 dividend stocks are rated a Buy by TheStreet
PBCT: 14.84 (+0.06), FCX: 28.51 (+0.21), EPD: 37.46 (+0.23)

Notable earnings after Thursday’s close
Seeking Alpha - at Seeking Alpha - Wed Oct 15, 4:35PM CDT

WDFC: 76.17 (-0.11), CCK: 48.37 (+0.83), WAL: 26.14 (-0.09), ASBC: 19.07 (-0.01), CYT: 49.08 (+0.28), GOOG: 535.64 (-8.76), SLB: 96.07 (+0.75), ATHN: 122.96 (-2.07), PBCT: 14.84 (+0.06), COF: 81.04 (-0.72), AMD: 2.65 (+0.04), XLNX: 43.45 (-0.16), CPHD: 52.71 (+0.40), QLGC: 11.66 (-0.08), WTFC: 46.06 (-0.28), SNDK: 97.13 (+0.94), SYK: 88.41 (+0.41)

People's United Financial (PBCT) Shows Signs Of Being Water-Logged And Getting Wetter
at The Street - Wed Oct 15, 10:42AM CDT
Trade-Ideas LLC identified People's United Financial (PBCT) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate
PBCT: 14.84 (+0.06)

Is People's United (PBCT) Likely to Disappoint Q3 Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 14, 4:15PM CDT
People's United (PBCT) is scheduled to report its third-quarter 2014 results on Thursday, Oct 16, after the closing bell.
PBCT: 14.84 (+0.06), COF: 81.04 (-0.72), AI: 27.27 (-0.02), CIT: 48.69 (-0.29)

People's United Financial Inc. (PBCT) Stock Research Links

PBCT Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MetroScape: Local Roots Fuel Bold DFW Growth Plans

A Local Business with Big Aspirations Here's the deal, folks: Local guys Dr. Marc Nickell and Chris Brewer snatched up MetroScape Landscape like it was the last slice of grandma's pie. Why? Not just for the greenbacks—they're putting down roots in their very own backyard, the Dallas-Fort Worth area. What Does Local Really Mean? Look, it's one thing hitting up a...

Ozelle's O-Cyte 1: Revolutionizing Hematology with AI

O-Cyte 1 Leads the Charge at MEDICA 2026 With all the chatter floating around the latest whiz-bang healthcare technology, it's downright refreshing to stumble upon something as genuinely promising as Ozelle's O-Cyte 1. Slated to be the talk of the town at this year’s MEDICA in DÜSSELDORF, this shiny new automated hematology analyzer promises to marry the best of AI and...

UPM Defies Market Challenges: Strong Q3 Cash Flow

UPM's Impressive Q3 Performance Amidst Challenges UPM-Kymmene Corporation just dropped their Q3 numbers, and let me tell ya, there's a lot to digest. In the face of some pretty gnarly market conditions—think destocking and those pesky cost inflations—they've managed to pull a rabbit out of the hat with strong cash flow. That's not a small feat, folks; it's a damn...

2021 Ferrari Portofino Shines Bright at Jake's Motorcars

San Diego might be known for its sunny weather, but Jake's Motorcars just cranked the heat with a 2021 Ferrari Portofino that flaunts a special-ordered Mandarin Orange interior. Now, if that doesn't scream "look at me," I don't know what does. For those who aren't just dabbling in Ferraris but are downright obsessed, let's dig into what makes this sports car not just...

Greek-Serbian Heads Meet to Prep for 2027 Tourism Expo

Breaking Cultural and Business Barriers You ever get that feeling when two neighbors finally decide to have a proper sit-down and hash things out? That's the vibe in Athens today, as Greek and Serbian movers and shakers are gathering to lay the groundwork for EXPO 2027 Belgrade. It's a match that's kinda hard to ignore if you're watching Europe's trade routes—especially...

Royce Micro-Cap Trust: Navigating Small-Cap Waves

Folks, if there's ever been a niche in this labyrinth of stocks, it’s the micro-cap territory. Royce Micro-Cap Trust (NYSE: RMT) is hefting the torch for smaller companies up to a billion in market cap. But is it leading the charge or getting steamrolled by market bear crawls? Understanding the Numbers Time to get dirty with some numbers, because for Royce Micro-Cap...

Ryde Group Faces Class Action: Key Investor Takeaways

Ryde Group's Tumble: More Than Just Market Volatility When RYDE shares nosedived like a lead balloon, it wasn't due to a market hiccup—it was a darn mess fueled by alleged manipulation. At the heart of this crash are accusations of a blatant pump-and-dump scheme that allegedly swindled investors out of millions. Pump-and-Dump: The Dirty Mechanics This ain't your regular...

White House Photographer Reveals Unseen Historic Moments

You don’t just wander into the White House and leave unimpressed, not if you're someone who lived it like David Hume Kennerly. Imagine stepping behind those gates and through history's lens, capturing moments few had the privilege to see. Kennerly's debut as the Chief White House Photographer was at a turning point in America, just after the Nixon saga collapsed in...

Ad Council Expands Board, Taps Meta Exec as Vice Chair

An Unexpected Shuffle at the Ad Council Alright, folks, let's talk shop about the recent shake-up in the nonprofit realm. The Ad Council, which has been around longer than some of the giants controlling today's marketing landscapes, just plumped up its Board of Directors with 23 new heavy-hitters. We're talking about leaders from every nook and cranny of the...

Medunik USA Ensures Steady Supply of Pheburane Amid Changes

There's a breath of relief in the air over at Medunik USA, where they're keeping a steady course amidst some choppy waters. Those dealing with urea cycle disorders (UCD) have had their fair share of ups and downs, but Pheburane® isn’t going anywhere anytime soon. Medunik USA Holds the Line So, picture yourself in the shoes of a patient battling a rare urea cycle...